Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.41 |
| ▸ | PPARG | P37231 | 3/20 | 0.41 |
| ▸ | OXER1 | Q8TDS5 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | RXRA | P19793 | 2/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.38 |
| ▸ | F7 | P08709 | 3/20 | 0.38 |
| ▸ | F3 | P13726 | 3/20 | 0.38 |
| ▸ | PPARA | Q07869 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | PPARD | Q03181 | 2/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.38 |
| ▸ | CNR1 | P21554 | 2/20 | 0.36 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4969578 | 1.00 | ALDH1A1 (0.41) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL1611678 | 1.00 | ALDH1A1 (0.41) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL1551787 | 1.00 | ALDH1A1 (0.41) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL17798928 | 1.00 | ALDH1A1 (0.41) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL10910041 | 1.00 | — | — | |
| SCHEMBL3387971 | 1.00 | — | — | |
| SCHEMBL21679678 | 1.00 | ALDH1A1 (0.41) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL21679677 | 1.00 | ALDH1A1 (0.41) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL21484057 | 1.00 | ALDH1A1 (0.41) | ALDH1A1CYP19A1PPARGOXER1MAPT | |
| SCHEMBL1611679 | 1.00 | ALDH1A1 (0.41) | ALDH1A1CYP19A1PPARGOXER1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3556464-B1 | METHOD FOR PRODUCING REDUCED HALIDE COMPOUND HAVING UNDERGONE REDUCTION OF CARBON-CARBON UNSATURATED BOND | SHINETSU CHEMICAL CO (JP) | 2023-08-02 | — | — | EP | disclosed |
| US-10676417-B2 | Method for producing reduced halide compound having undergone reduction of carbon-carbon unsaturated bond | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-06-09 | — | — | US | disclosed |
| US-20190322607-A1 | METHOD FOR PRODUCING REDUCED HALIDE COMPOUND HAVING UNDERGONE REDUCTION OF CARBON-CARBON UNSATURATED BOND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2019-10-24 | — | — | US | disclosed |
| EP-3556464-A1 | METHOD FOR PRODUCING REDUCED HALIDE COMPOUND HAVING UNDERGONE REDUCTION OF CARBON-CARBON UNSATURATED BOND | Shin-Etsu Chemical Co., Ltd. (JP) | 2019-10-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190322607-A1 | METHOD FOR PRODUCING REDUCED HALIDE COMPOUND HAVING UNDERGONE REDUCTION OF CARBON-CARBON UNSATURATED BOND | CBR1, CBR3, DECR1 | ALDH1A1 907/4885CYP19A1 691/4885PPARG 1240/4885 |
| US-10676417-B2 | Method for producing reduced halide compound having undergone reduction of carbon-carbon unsaturated bond | CBR1, CBR3, DECR1 | ALDH1A1 907/4885CYP19A1 691/4885PPARG 1240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.